consumption of animal fat since 1909 actually decreased by 10 percent, whereas vegetable fat increased by over 200 percent. The increase of heart attacks has paralleled the increased use of margarine, homogenized milk and processed foods such as sugar.
According to Judith DeCava, in her book, Cholesterol, Facts and Fantasies, in one study, almost half of the patients had total cholesterol levels under 200, which is supposed to be safe. Yet half of this group had coronary heart disease. Of the almost 1200 who did have heart disease, one third had cholesterol levels under 200. Dr. Michael DeBakey, the famous heart surgeon, reports that 30 percent of patients who have a coronary bypass have “normal” cholesterol levels.”
The Real Culprit
Here’s what IS clearly linked to heart disease: sugar. Judith DeCava, in her excellent book, Cholesterol, Facts and Fantasies states,
“John Yukin analyzed the refined sugar consumed by men with atherosclerosis. The men who had heart attacks ate almost twice as much sugar as those who not having heart attacks. In fact, in persons with coronary heart disease, the degree of atherosclerosis was proportional to the amount of refined sugar consumed.” (The Lancet 1964); 2 (7349):6-8.
As further evidence of this is the fact that the consumption of fat in the Caribbean countries is very low, but the use of sugar is very high. Cuba has one of the highest levels of sugar use, and has a higher death rate from heart attacks in men between ages 55 and 64 than the U.S.!
The Fox Guarding the Hen House
So what’s perpetuating this campaign of misinformation? It’s the money from the drug companies who want you to buy their cholesterol reducing drugs (that have serious side affects) and from the food industries that benefit from this scam.
Here are some examples. The American Medical Association’s Executive Vice-President, Dr. James Sammons, promised physicians in 1988 of their financial rewards by stating, “the AMA’s campaign against cholesterol will bring both old and new patients to you for necessary testing, counseling and care.”
One researcher who later became a director of the National Institutes of Health bought stock in a pharmaceutical company just before announcing the results of a study favorable to the drug’s effects. The editor of the AMA’s publication, Circulation, also received stock options on the same drug company.
Jane Heimlich began doing extensive research on this cholesterol issue in 1989. In her book, What Your Doctor Won’t Tell You, she concludes,
“There is no question that the cholesterol program…benefits three powerful groups in our society to the tune of billions of dollars. These three are the medical profession, the pharmaceutical industry, and the food companies.”
About the Author
Ray Gebauer is a M.D. of a different sort--he is Mission Driven to save lives with a revolutionary technology that even MIT claims can "change the world." As the author of the popular groundbreaking book, How to Cure and Prevent Any Disease, his passion is to educate people as to how to escape the invisible and socially acceptable trap of degenerative diseases that needlessly kill 90% of Americans.
Written By: Ray Gebauer

Pfizer: US ruling maintains Lipitor patent term - PR Inside
TRENTON, New Jersey (AP) - The U.S. Patent & Trademark Office on Tuesday issued a notice allowing drugmaker Pfizer Inc. to correct a technical defect in one of the patents involving Pfizer's cholesterol medicine Lipitor, the world's top-selling drug ...
Using Nature's Indicators To Avoid Environmental Disasters - Redorbit.com
Economists use leading indicators — the drivers of economic performance – to take the temperature of the economy and predict the future. Now, in a new study, scientists take a page from the social science handbook and use leading indicators of ...
Pfizer wins patent extension on cholesterol drug - Newark Star-Ledger
The U.S. Patent & Trademark Office today said it will accept drugmaker Pfizer Inc.'s application to correct a technical defect in one of the patents involving Pfizer's cholesterol medicine Lipitor, the world's top-selling drug. The decision would ...
Testing for Heart Risk More Cheaply - Time
More than 500,000 women in the U.S. die each year of cardiovascular disease, making it, not breast cancer (40,000 deaths annually), their No. 1 killer Posted Friday, Mar. 14, 2008 Here's a quick quiz: what's the world's No. 1 killer? It's not AIDS ...
Millions of older Americans use risky drug combos - Associated Press
CHICAGO (AP) -- At least 2 million older Americans are taking a combination of drugs or supplements that can be a risky mix - from blood thinners and cholesterol pills to aspirin and ginkgo capsules - a new study warns. Among older men, the numbers ...